Yüklüyor......
Preventing Cushing: Iatrogenic Cushing Syndrome due to Ritonavir-Fluticasone Interaction
Ritonavir is commonly used in low doses to boost plasma levels of protease inhibitors in patients with human immunodeficiency virus (HIV) infections. It is also a potent inhibitor of cytochrome P450. We present a 50-year-old African American male with past medical history of HIV on highly active ant...
Kaydedildi:
| Yayımlandı: | Cureus |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cureus
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5602273/ https://ncbi.nlm.nih.gov/pubmed/28944123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1484 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|